Article

Open Innovation: Transforming the Model of Biopharmaceutical R&D

Don Frail, Vice President, AstraZeneca Innovative Medicines Group discusses the company's approach to innovation and the upcoming session at the BIO International Convention

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
medical ampoules packaging | Image Credit: © macondos - © macondos - stock.adobe.com
August 31st 2025

SGD Pharma to Acquire Alphial Tubular Glass Manufacturer

Feliza Mirasol
Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?
August 31st 2025

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 31st 2025

FDA Grants Breakthrough Therapy Designation to Bispecific ADC for EGFR-Mutant Lung Cancer

Feliza Mirasol
Site Logo
August 31st 2025

Vaccines and Virus Purification through the Ages

High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com
August 31st 2025

Next for Biopharma: Speed, Strategy, and Smarter Systems

Mike Hennessy Jr.
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 31st 2025

European TICC group, Normec, Gains Foothold in US Market with Three Strategic Acquisitions

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.